Agenda - Gold Sponsors' Satellite Symposium| From selectivity to safety: Selective JAK1 inhibition as a basis for a wide margin of safety

Gold Sponsors' Satellite Symposium| From selectivity to safety: Selective JAK1 inhibition as a basis for a wide margin of safety

Tracks

Crystal Hall

Monday, June 29, 2026

1:30 PM - 2:30 PM

Sponsored By:

MSD

Speaker

Dr. Timothy Kowalski

Intervet Inc., (d/b/a Merck Animal Health)

Atinvicitinib, a second-generation JAK inhibitor, highly selective for JAK1

Dr. Inka Kuhlmann

Director, Global Pharmaceutical Development

MSD Animal Health Innovation GmbH

Clinically favorable safety profile of the second-generation JAK inhibitor atinvicitinib in dogs

Chair

Agenda Item Image

Georgios Batzias

Professor of Veterinary Clinical Pharmacology

Aristotle University of Thessaloniki

Christopher Zdyrski

Lab Manager

University of Georgia

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript